Edition:
India

Profile: Gufic Biosciences Ltd (GUFI.BO)

GUFI.BO on Bombay Stock Exchange

68.10INR
22 Aug 2017
Change (% chg)

Rs-1.05 (-1.52%)
Prev Close
Rs69.15
Open
Rs69.00
Day's High
Rs70.00
Day's Low
Rs67.70
Volume
7,161
Avg. Vol
211,503
52-wk High
Rs79.55
52-wk Low
Rs33.30

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Pharma, including Formulations and Bulk Drugs, and Consumer. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro Fe, Vipro M and Zad G, and Herbal, including Bocomo-Forte, River-Suspension, Sallaki-Liniment, Sallaki-Plus, Sallaki-XT and Smashit. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole, Everolimus and Butoconazole. It manufactures APIs under therapeutic categories, such as Antifungals and Immuno Suppressants.

Company Address

Gufic Biosciences Ltd

Gufic House
Sobhash Road, Vile Parle East
MUMBAI     400057
P: +9122.67261000
F: +9122.26169008

Company Web Links